Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.8 USD | -0.48% | +4.74% | +54.40% |
31/05 | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
31/05 | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
Sales 2024 * | 187.89Cr 18Cr 1.49TCr | Sales 2025 * | 320.1Cr 31Cr 2.54TCr | Capitalization | 1.12TCr 106.79Cr 8.87TCr |
---|---|---|---|---|---|
Net income 2024 * | -3.8Cr -36.32L -30Cr | Net income 2025 * | 112.4Cr 11Cr 892.59Cr | EV / Sales 2024 * | 5.88 x |
Net cash position 2024 * | 13Cr 1.2Cr 99Cr | Net cash position 2025 * | 120.53Cr 12Cr 957.13Cr | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
37.4
x | P/E ratio 2025 * |
9.03
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.29% |
Latest transcript on Calliditas Therapeutics AB
1 day | -0.48% | ||
1 week | +4.74% | ||
Current month | -0.60% | ||
1 month | +98.75% | ||
3 months | +88.39% | ||
6 months | +122.75% | ||
Current year | +54.40% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 18/17/18 | |
Director of Finance/CFO | 47 | 01/17/01 | |
Chief Tech/Sci/R&D Officer | 60 | 24/20/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 30/23/30 |
Henrik Stenqvist
BRD | Director/Board Member | 57 | 01/22/01 |
Elmar Schnee
CHM | Chairman | 65 | 08/19/08 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 39.75 | -0.60% | 12 384 |
31/24/31 | 39.99 | +3.95% | 49,364 |
30/24/30 | 38.47 | +1.40% | 90,047 |
29/24/29 | 37.94 | -0.03% | 54,142 |
28/24/28 | 37.95 | +69.27% | 218,781 |
Delayed Quote Nasdaq, June 03, 2024 at 07:45 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.10% | 7.85TCr | |
+13.10% | 900.15Cr | |
+58.17% | 496.1Cr | |
-14.94% | 483.61Cr | |
-.--% | 372.43Cr | |
+20.17% | 247.76Cr | |
-26.63% | 218.54Cr | |
+16.75% | 211.67Cr | |
-37.97% | 194.2Cr |
- Stock Market
- Equities
- CALTX Stock
- CALT Stock